SARS-CoV-2 breakthrough infections in vaccinated individuals: measurement, causes and impact
M Lipsitch, F Krammer, G Regev-Yochay… - Nature Reviews …, 2022 - nature.com
Breakthrough infections with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …
2) in fully vaccinated individuals are receiving intense scrutiny because of their importance …
Immunity to SARS‐CoV‐2 induced by infection or vaccination
Adaptive immune responses play critical roles in viral clearance and protection against re‐
infection, and SARS‐CoV‐2 is no exception. What is exceptional is the rapid …
infection, and SARS‐CoV‐2 is no exception. What is exceptional is the rapid …
Viral loads of Delta-variant SARS-CoV-2 breakthrough infections after vaccination and booster with BNT162b2
M Levine-Tiefenbrun, I Yelin, H Alapi, R Katz… - Nature medicine, 2021 - nature.com
The effectiveness of the coronavirus disease 2019 (COVID-19) BNT162b2 vaccine in
preventing disease and reducing viral loads of breakthrough infections (BTIs) has been …
preventing disease and reducing viral loads of breakthrough infections (BTIs) has been …
Komunikasi Publik Terkait Vaksinasi Covid 19
SAE Dewi - Health Care: Jurnal Kesehatan, 2021 - jurnal.payungnegeri.ac.id
Pemerintah telah menetapkan bahwa pandemic Coronavirus Disease 2019 (COVID-19)
sebagai bencana non-alam. Hingga tahun 2021 Pandemi covid-19 masih berlanjut …
sebagai bencana non-alam. Hingga tahun 2021 Pandemi covid-19 masih berlanjut …
Waning of SARS-CoV-2 booster viral-load reduction effectiveness
M Levine-Tiefenbrun, I Yelin, H Alapi, E Herzel… - Nature …, 2022 - nature.com
Abstract The BNT162b2 COVID-19 vaccine has been shown to reduce viral load of
breakthrough infections (BTIs), an important factor affecting infectiousness. This viral-load …
breakthrough infections (BTIs), an important factor affecting infectiousness. This viral-load …
[HTML][HTML] Effectiveness of an inactivated SARS-CoV-2 vaccine
A Wilder-Smith, K Mulholland - New England Journal of Medicine, 2021 - Mass Medical Soc
The world needs more vaccines against severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), in order to …
(SARS-CoV-2), the virus that causes coronavirus disease 2019 (Covid-19), in order to …
Beschlussentwurf der STIKO zur 4. Aktualisierung der COVID-19-Impfempfehlung und die dazugehörige wissenschaftliche Begründung
S Vygen-Bonnet, J Koch, C Bogdan, T Harder… - 2021 - edoc.rki.de
Die STIKO empfiehlt die Impfung gegen COVID-19 mit einem der beiden zugelassenen
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …
mRNA-Impfstoffe (Comirnaty von BioNTech/Pfizer, COVID-19-Vaccine von Moderna) oder …
SARS-CoV-2 variants, immune escape, and countermeasures
Y Zhang, H Zhang, W Zhang - Frontiers of medicine, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19) has become a global pandemic disease.
SARS-CoV-2 variants have aroused great concern and are expected to continue spreading …
SARS-CoV-2 variants have aroused great concern and are expected to continue spreading …
COVID‐19 and plasma cells: Is there long‐lived protection?
DC Nguyen, PA Lamothe, MC Woodruff… - Immunological …, 2022 - Wiley Online Library
Summary Infection with SARS‐CoV‐2, the etiology of the ongoing COVID‐19 pandemic, has
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …
resulted in over 450 million cases with more than 6 million deaths worldwide, causing global …
Waning antibody responses in COVID-19: what can we learn from the analysis of other coronaviruses?
A Hamady, JJ Lee, ZA Loboda - Infection, 2022 - Springer
Objectives The coronavirus disease 2019 (COVID-19), caused by the novel betacoronavirus
severe acute respiratory syndrome 2 (SARS-CoV-2), was declared a pandemic in March …
severe acute respiratory syndrome 2 (SARS-CoV-2), was declared a pandemic in March …